Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CFH guide en español

This article was originally published in The Tan Sheet

Executive Summary

Council on Family Health, in partnership with FDA, National Consumers League, introduces new Spanish-language guide to educate Latino community on drug interactions. Pamphlet explains different types of interactions, stresses importance of reading labels and warning information. Guide also contains chart of drug interaction warnings for common OTCs. Brochure is available by mail from CFH and on their web site at

You may also be interested in...

FDA, CFH promote self care

FDA and the Council on Family Health are encouraging people to "take a more active role" in personal healthcare in a 1booklet titled "Be An Active Member of Your Health Care Team." Developed by the agency in cooperation with CFH, the brochure features information to help consumers make more informed choices and urges greater communication between patients and their health care professionals. CFH and FDA previously issued a guide aimed at the Latino community on drug interactions and the importance of reading labels (2"The Tan Sheet" May 20, 2002, In Brief)...

Sales Already Growing As Vascepa Secures Cardio Approval

Company forecasts 2020 sales as high as $700m after regulator grants broad label.

Another EU MDR Notified Body In The Netherlands

Last week, the European Commission revealed that three more notified bodies had been designated, but their listings had not been made official. Now we learn that one of the three is in the Netherlands as the first listing takes place.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts